Cardinal Health INC: insider trades · United States · SEC (Form 4)

About Cardinal Health INC

Cardinal Health Inc. (NYSE: CAH) is a United States-listed healthcare services and products company headquartered in Dublin, Ohio, United States. The company was formally formed in 1979, while its operating roots go back to 1971, when it began as a regional food distributor before shifting into healthcare. Today, Cardinal Health is an essential infrastructure player in the U.S. healthcare system, serving pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, and physician practices with products and services designed to improve supply-chain efficiency and lower the cost of care. ([cg.cardinalhealth.com](https://cg.cardinalhealth.com/corporate-responsibility/default.aspx?utm_source=openai)) Cardinal Health currently reports results through two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The first segment covers pharmaceutical distribution and specialty-related services, while the second includes medical products, manufacturing, distribution, and broader supply-chain solutions. This structure reflects a business model centered on high-volume logistics, procurement, and healthcare workflow support rather than on consumer-facing healthcare brands. The company’s scale and long-standing customer relationships make it one of the most important intermediaries between drug/device manufacturers and care delivery sites, with a strong North American footprint and selective international activities. ([ir.cardinalhealth.com](https://ir.cardinalhealth.com/files/doc_financials/2026/q1/10-Q.pdf?utm_source=openai)) Its offering spans prescription drug distribution, medical-surgical products, logistics services, home-based care supply solutions, and specialty platforms. Recent materials also highlight at-Home Solutions, OptiFreight Logistics, and Nuclear and Precision Health Solutions as meaningful growth and diversification areas. That mix gives Cardinal Health exposure to recurring healthcare demand and mission-critical distribution flows, while still leaving it sensitive to pricing pressure, reimbursement trends, customer concentration, and regulatory scrutiny that typically affect large healthcare distributors. ([newsroom.cardinalhealth.com](https://newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance?utm_source=openai)) From a competitive standpoint, Cardinal Health is one of the leading U.S. pharmaceutical and medical distribution platforms. Its competitive advantages come from network density, scale economics, logistics capabilities, and embedded customer relationships across the healthcare ecosystem. The company has also been repositioning its portfolio toward higher-value services and more specialized healthcare activities, helping improve mix and support longer-term margin expansion. ([cg.cardinalhealth.com](https://cg.cardinalhealth.com/corporate-responsibility/default.aspx?utm_source=openai)) Recent news flow has been constructive. On April 30, 2026, Cardinal Health reported third-quarter fiscal 2026 results and raised its full-year outlook. Earlier in fiscal 2026, it also lifted guidance after second-quarter results and continued a sizable accelerated share repurchase program, indicating confidence in cash generation and balance-sheet discipline. For investors, CAH is best viewed as a defensive healthcare operator with a critical logistics role, stable end-market demand, and strategic optionality through specialty expansion and targeted acquisitions. ([prnewswire.com](https://www.prnewswire.com/news-releases/cardinal-health-reports-third-quarter-fiscal-year-2026-results-and-raises-outlook-302758658.html?utm_source=openai))